ceprotin
takeda manufacturing austria ag - cilvēka olbaltumviela c. - purpura fulminans; protein c deficiency - antitrombotiskie līdzekļi - ceprotin is indicated for prophylaxis and treatment of purpura fulminans coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.
vpriv
takeda pharmaceuticals international ag ireland branch - velaglucerase alfa - gošē slimība - citas gremošanas trakta un metabolisma produkti, - vpriv ir indicēts ilgstošai enzīmu aizstājterapijai (ert) pacientiem ar 1. tipa gošē slimību.
kliane 1 mg/2 mg apvalkotās tabletes
bayer ag, germany - norethisteroni acetas, estradiolum hemihydricum - apvalkotās tabletes - 1 mg/2 mg
ibudolor 200 mg apvalkotās tabletes
stada arzneimittel ag, germany - ibuprofēns - apvalkotā tablete - 200 mg
escitasan 10 mg apvalkotās tabletes
stada arzneimittel ag, germany - escitaloprāms - apvalkotās tabletes - 10 mg
escitasan 20 mg apvalkotās tabletes
stada arzneimittel ag, germany - escitaloprāms - apvalkotās tabletes - 20 mg
livtencity
takeda pharmaceuticals international ag ireland branch - maribavir - citomegalovīrusu infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). jāņem vērā oficiālās vadlīnijas par piemērotu izmantot pretvīrusu aģentu.
meloxistad 7,5 mg tabletes
stada arzneimittel ag, germany - meloksikāms - tablete - 7,5 mg
meloxistad 15 mg tabletes
stada arzneimittel ag, germany - meloksikāms - tablete - 15 mg
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmoloģiskie līdzekļi - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).